Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-06

Clinical Trial Update: MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating MRD-guided consolidation therapy after definitive radiotherapy in esophageal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING